Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long LLY ETF

29.01
-0.3250-1.11%
Pre-market: 29.070.0692+0.24%04:37 EDT
Volume:131.05K
Turnover:3.78M
Market Cap:45.68M
PE:- -
High:29.36
Open:29.33
Low:28.25
Close:29.33
52wk High:31.19
52wk Low:12.18
Shares:1.57M
Float Shares:1.57M
Volume Ratio:0.41
T/O Rate:8.32%
Dividend:0.70
Dividend Rate:2.43%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly SVP Finance & CAO Donald A. Zakrowski Lepas 2.000 Saham Senilai USD 2,37 Juta

Reuters
·
Aug 12

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 12

Rothschild & Co Redburn Adjusts Eli Lilly and Co. PT to $915 From $900, Keeps Neutral Rating

MT Newswires Live
·
Aug 12

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly

Morning Star
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Eli Lilly's Foundayo Gains First European Approval, Igniting Global Oral Weight-Loss Drug Battle

Deep News
·
Aug 11

What Does Eli Lilly (LLY) Gain From Its Oncology Push And New Funding Bet?

Simply Wall St.
·
Aug 11

MHRA authorizes Eli Lilly’s weight loss pill Foundayo in UK

TIPRANKS
·
Aug 11

Eli Lilly and Co Stock (LLY) Moved Up by 3.48% on Aug 10: Drivers Behind the Movement

TradingKey
·
Aug 11

Eli Lilly Rises After UK Regulator Approves Weight-Loss Drug

Reuters
·
Aug 11

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 10

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07